ICP, CPP, and MAP values were analyzed. Of these, 17 patients had undergone continuous perioperative digital ICP recording with online waveform analysis, in addition to the basic physiological parameters.
Patients and their clinical characteristics are summarized in Table 1 . Twenty patients presented with severe head injury (GCS score Յ 8). Seven patients were initially in a moderate injury group (based on a postresuscitation GCS score of 9-12), but their condition deteriorated and they required intubation. All patients were treated in a specialized neurocritical care unit with ICP and CPP protocol-driven therapy. 21 The aim was to maintain CPP of Ն 60-70 mm Hg and ICP of Յ 25 mm Hg, and new treatment measures were introduced if the current therapy failed to achieve or maintain these goals. These measures included head elevation, sedation, analgesia and paralysis, intravenous fluids and inotropes, moderate hyperventilation, cerebrospinal fluid drainage via ventriculostomy, controlled hypothermia, osmotic agents, and barbiturates.
Decompressive craniectomy was performed when other advanced methods of ICP control or CPP augmentation failed. This procedure was performed on median Day 3 (range 0-10 days). Twenty-one patients (78%) underwent bifrontal and 6 (22%) had unilateral decompressive craniectomy. In all cases a large (Ն 100 cm 2 ) decompressive craniectomy was performed and the dura mater was opened as part of the operation. The same intensive care management protocol was used in the postoperative period, and the intensity of therapy was tailored to achieve the same ICP and CPP targets.
Monitoring of ICP
In all patients, ICP was monitored using a parenchymal ICP sensor (Codman) inserted with the aid of a triple-lumen access device (Technicam), 16 positioned in the right or left frontal area.
The ICP sensor was either preserved or reinserted in the operating theater immediately after decompressive craniectomy by using the access device placed in the same frontal region through a new scalp incision made away from the surgical wound. Direct placement of the ICP monitor under the scalp flap was not performed.
We used ICM+ software, which was developed inhouse, 13 for continuous bedside acquisition of physiological parameters, online ICP waveform analysis, and computation of ICP waveform-derived indices.
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Analysis of the ICP Waveform
The ICP waveform 3 can be separated into 3 distinct components of different frequencies: pulse waveform, respiratory waveform, and "slow waves" (Lundberg B waves). Pulse waveform can in turn be divided into several harmonic components, of which the most prominent has a frequency equal to the heart rate. The amplitude of this component (which we will call AMP) can be used to derive the RAP index. The RAP is the correlation coefficient between the AMP and the mean ICP produced by a linear correlation between 40 consecutive, time-averaged (over 6 to 10 seconds) data points of AMP and ICP. It represents the relationship between ICP and changes in volume of the intracranial space (reflected by AMP), commonly defined as a "pressure-volume curve," and is an equivalent of cerebral compliance. When the value of RAP is close to 0, there is no synchronization between changes in AMP (intracranial volume) and ICP, and therefore, there is good pressurevolume compensation. A high correlation between AMP and ICP (RAP close to 1) indicates that pressure-volume compensatory reserve is exhausted and that further increases in volume will lead to the rise in ICP (Fig. 1) .
The response of ICP to changes in ABP reflects the reactivity of cerebral blood vessels. A normally reactive cerebral arterial bed constricts in response to a rise in arterial pressure, causing a simultaneous decrease in ICP. The dynamic relationship between ABP and ICP can be assessed using the PRx, which is a correlation coefficient between 40 consecutive (6-10 seconds averaged) data points of ICP and ABP. Negative values of the PRx indicate that increases in ABP correlate with decreases in ICP, and therefore, cerebrovascular pressure reactivity is likely to be intact. Conversely, positive values signify that increases in ABP are associated with simultaneous increases in ICP, and therefore, cerebral vasculature is less reactive or nonreactive.
Statistical Analysis
Data were analyzed using SPSS 14.0 software (SPSS Inc.) on a Windows XP platform. For comparison of values of monitoring parameters before and after decompressive craniectomy, data were averaged for the total pre-and postoperative periods. To assess the temporal profile of changes, further time epochs were defined: initial period (time from admission to the time point 24 hours prior to operation), 24-and 3-hour periods before craniectomy; 3- and 24-hour periods after the operation, and Day 2 and Day 3 (subsequent 24-hour periods) following craniectomy. Data were averaged around these time points, and a single value was used per patient in the final analysis. We did not include data obtained beyond 72 hours after craniectomy, because in many patients monitoring had been discontinued. Due to the small sample size, most parameters were not normally distributed, and therefore, nonparametric statistical methods were used. All values are expressed as the median, with the IQR in brackets, and a probability value of Յ 0.05 was considered significant unless indicated otherwise in the corresponding text.
Results
The values of the physiological parameters before and after craniectomy are presented in Tables 2 and 3 .
The ICP progressively increased during the preoperative period. Surgical decompression led to significant reduction in ICP, which was sustained for at least 72 hours after operation, with the median values of ICP Ͻ 20 mm Hg ( Fig.  2A) . The study sample size precluded the use of multiple regression analysis for adequate assessment of all the factors influencing ICP after decompressive craniectomy. Nevertheless, we explored the relationships between individual factors and postoperative ICP. Severity of injury and time from injury to decompression were not correlated with ICP after decompressive craniectomy. There was also no significant association between ICP control and the type of craniectomy. The age of the patient was the only factor correlated with the postoperative ICP levels; older patients tended to have lower ICP (r = Ϫ0.667, p = 0.003, Pearson correlation), and this relationship remained significant even after controlling for preoperative ICP levels (r = Ϫ0.516, p = 0.41, partial correlation).
A similar temporal pattern was observed in the changes of the RAP index. The RAP increased toward the value of 1.0 before decompression, indicating loss of compensatory reserve, and improved dramatically following craniectomy (Fig. 2B) . Furthermore, the median values of RAP at the same ICP ranges were significantly lower after the operation (Table 4 ; Fig. 3A ).
The amplitude of slow waves decreased in line with ICP and RAP values in the postoperative period.
The MAP decreased after decompressive craniectomy and remained significantly lower postoperatively. The median CPP was maintained above 70 mm Hg before and after decompression, but there was considerable variability in the 3 hours preceding decompressive craniectomy, as reflected by the wide IQR (Fig. 2C) .
Following craniectomy, the PRx demonstrated a sustained increase toward positive values (Fig. 2D ), although the median PRx remained below the previously suggested 3 threshold of significant derangement ~ 0.2).
To assess the degree and overall impact of intracranial hypertension and derangements in cerebrovascular pressure reactivity before and after decompressive craniectomy, we calculated the proportion of time that ICP, CPP, and PRx deviated from the desired therapeutic targets (Fig. 4) Although the small data set did not allow conclusions about the impact of physiological parameters on outcome, postoperative PRx derangement was seen almost universally (in all but 1 patient). We evaluated the relationship between postoperative PRx and neurological outcome at 6 months based on the dichotomized GOS score. 18 In the study group, median postoperative PRx values were significantly higher in patients who died or had unfavorable outcome than in those with favorable neurological outcome (0. 19 
Discussion
In this study we investigated the effects of decompressive craniectomy on physiological parameters and measures of RAP and cerebrovascular pressure reactivity in patients with refractory intracranial hypertension following TBI. The results suggest that decompressive craniectomy can lead to a sustained reduction in ICP and MAP and improvement in cerebral compliance. Nevertheless, concurrent derangement in cerebrovascular pressure reactivity also occurs. The impact of this on neurological outcome requires further evaluation.
Intracranial pressure is associated with poor outcome after head injury, and ICP-guided therapy is widely used, 5, 28 despite the lack of Class I evidence that ICP measurement and control improves neurological outcome.
Decompressive craniectomy is not a new concept. It has been used since ancient times and has been attracting interest for more than a century as a method for treating severe brain edema secondary to a variety of conditions. The effect of decompressive craniectomy on clinical outcome is unknown 25, 29 and needs to be evaluated in a prospective randomized trial. Nevertheless, improvement in some physiological surrogate end points, 4, 27 including ICP, 14,26,31,32,34 has been reported after craniectomy. Longer-term ICP dynamics as well as the effect of decompressive craniectomy on other ICP-derived parameters reflecting cerebral autoregulation have not been previously described in detail.
Limitations of the Study
Direct comparison of preoperative and postoperative values of ICP may be subject to unavoidable measurement error. Postoperative values may be affected by the proximity of the ICP sensor to the large craniectomy defect and, therefore, may not accurately represent global ICP values. To minimize this effect, the ICP sensor was always placed via a separate bur hole away from the craniectomy wound in our patients after decompressive craniectomy. Parenchymal ICP sensors could also be subject to zero drift with time. The latter is usually minimal (Ͻ 1 mm Hg) 10, 19 and unlikely to have significant impact. However, despite the possibility of inaccuracy, ICP values continue to be used in clinical practice after decompressive craniectomy, and therefore, analysis of the postoperative ICP dynamics is worthwhile.
Other limitations of this study are the retrospective design and small sample size. The latter is mostly due to logistical difficulties with data capture before decompression. This may introduce selection bias toward patients in whom edema is developing more gradually and in whom there is enough time for preoperative recordings. Although the lack of a control group weakens the results, finding an equal number of patients with intractable intracranial hypertension who did not undergo decompressive craniectomy was not possible for this study because almost all such patients did have the procedure, as was dictated by the ICP protocol in our center.
Nevertheless, this data set provides important data on physiological parameters in the same patient before and after decompressive craniectomy.
Findings for ICP
Although the median ICP was generally higher during the whole preoperative period, significant ICP increases were observed in all patients in the last 24 hours prior to craniectomy, indicating progression of cerebral edema, despite escalation of therapy. The ICP was at its highest in the last 3 hours before decompression, well above accepted ICP thresholds, indicating the exhaustion of therapeutic options and the rationale for craniectomy. The ICP was lowest immediately after decompression, in line with previous reports, 23, 34 but increased gradually over the first 24 hours. However, it remained stable and well controlled for the following 48 hours, allowing reduction in intensity of treatment and weaning in most patients. The beneficial effect of decompressive craniectomy on control of ICP is also reflected in the proportion of time during which ICP was Ͼ 25 mm Hg. After decompressive craniectomy this occurred only 2% of the time, compared with nearly one third of the time preoperatively.
The lack of association between the craniectomy size and postoperative ICP values may be explained by the fact that bifrontal and unilateral decompressive craniectomies performed in our unit are equally large (~ 100-150 cm 2 ) and the dura mater is left open in all cases.
The association between increasing age and lower postoperative ICP is in agreement with our previous report 9 and may be due to age-dependent reduction of cerebral volume relative to the cranial cavity.
Findings for MAP and CPP
Progressive brain swelling with corresponding increases in ICP had an effect on the preoperative values of MAP. Despite a nonsignificant trend of reduced CPP, this physiological parameter was maintained at target levels prior to decompressive craniectomy. However, this was achieved at the expense of escalation of therapy and increased MAP. Aggressive MAP augmentation is associated with substantial risks for the patient. 7, 24 Decompressive craniectomy, by reducing ICP, led to a significant reduction in the required MAP. Lower MAP is likely to indicate reduced intensity of treatment and may reflect reduced inotropic requirements in the postoperative period.
Cerebrospinal Compensation and Cerebrovascular Pressure Reactivity
The relationship between the intracranial volume and pressure follows the "pressure-volume" curve (Fig. 1) . The initial "flat" part of the curve indicates that increases in intracranial volume can be tolerated with minimal or no increases in ICP. The "steep" part of the curve corresponds to the impaired pressure-volume reserve, when even small increases in intracranial volume lead to large increases in ICP. Most patients with raised ICP have reduced cerebral compliance corresponding to the "steep" part of the curve. Decompressive craniectomy provides extra space for intracranial contents and should in theory improve compensatory reserve. This agrees with Abdullah et al., 2 who recently reported improvement in compliance and pressure-volume index after decompressive craniectomy.
We used an ICP-derived index, RAP, to evaluate the dynamics of pressure-volume compensatory reserve, before and after decompressive craniectomy. Before surgery, RAP was closer to 1, indicating reduced compliance, with the highest values in the final 3 hours. After craniectomy, RAP improved dramatically and remained near 0, indicating improved pressure-volume reserve. Moreover, similar levels of ICP were associated with lower RAP values following decompression. This implies that even those patients with higher postoperative ICP have better pressurevolume compensation after decompression ("flatter" part of the curve, Fig. 3B ) and are able to tolerate larger intracranial volume expansions.
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Intracranial pressure and cerebrospinal compensation The amplitude of slow waves decreased following decompressive craniectomy, probably reflecting reduced ICP and an improved pressure-volume relationship. Although very low values have previously been linked to increased mortality rates, 3 the median values in our patient group exceeded those associated with poor outcome. There was no statistically significant difference in the amplitude of slow waves between different outcome groups.
The PRx, which reflects the reactivity of cerebral blood vessels to changes in arterial pressure, changed to more positive values in all but 1 patient in this study. In this patient, PRx was severely deranged before decompressive craniectomy and remained unchanged afterward. High postoperative values of PRx were recently reported by Wang et al. 30 in a series of patients evaluated after decompressive craniectomy and compared with control patients treated with medical therapy alone. In their series, PRx improved with time in the postcraniectomy group but did not change in the medical therapy group. Our data, which also allow evaluation of preoperative PRx, suggest that even patients in whom cerebrovascular pressure reactivity was preserved before craniectomy (that is, negative PRx values) had positive values after craniectomy, indicating acquired derangement. Moreover, there was no significant improvement in PRx scores within a 72-hour time frame. The proportion of time that PRx remained Ͼ 0.2, representing significant impairment of pressure reactivity, was also significantly higher after craniectomy (~ 40% of the time). Although associations between postoperative but not preoperative PRx values and outcome in our patients are intriguing, the sample size limits further conclusions.
The origin of this derangement is not clear, and it is not known whether PRx remains a reliable indicator of pressure reactivity following craniectomy. Altered cerebralcranial relations with brain shifts and exposure to atmospheric pressure may play some role in the reduced reaction of cerebral blood vessels to changes in pressure. Improvement in cerebral RAP may also need to be taken into account when interpreting the PRx values following craniectomy, because some of the ABP increases may cause vasodilation without concurrent increases in ICP in the presence of good cerebral compliance. This is more likely to cause low or negative PRx values in the presence of disturbed reactivity, however, making the PRx less sensitive. In our patients PRx values increased despite significant improvement in cerebral compliance, and may represent even more substantial derangement in cerebrovascular reactivity.
Another possible explanation for such pronounced change in pressure reactivity is the development of postdecompression hyperemia with associated vasoparesis or a cerebral equivalent of "reperfusion" syndrome, which have been described in other parts of the body when prolonged compression is relieved. Yamakami and Yamaura 33 reported a substantial increase in regional CBF in the decompressed brain regions. This hyperperfusion progressed for up to 1 week after decompressive craniectomy and correlated with the degree of brain edema on conventional computed tomography scans. Other recent reports, suggesting that CBF 4 and brain tissue oxygen values 27 after decompressive craniectomy may increase by up to 200%, reaching levels much higher than expected in normal physiology, also support this interpretation. Whether altered vascular reactivity is related to the increases in cerebral edema after decompressive craniectomy 8 needs to be confirmed. Moreover, the relationship between deranged cerebrovascular pressure reactivity following decompressive craniectomy and outcome needs to be further explored in a larger series, because PRx may become an important monitoring parameter to guide therapy and define CPP targets after decompression, particularly in the presence of normal ICP. Further studies are also required to define the optimum levels of CPP in these patients, because it is possible that very high CPP targets may predispose these individuals to exacerbation of hyperemia and associated brain edema. In addition, due to improved pressure-volume compensation after craniectomy, cerebral swelling may progress substantially before a significant increase in ICP is detected.
Conclusions
The results of this study support the following theories: 1) Decompressive craniectomy leads to sustained reduction in ICP and improved cerebral pressure-volume compensation. 2) Following decompressive craniectomy, adequate CPP levels can be achieved at lower MAP levels. This may reduce the load on the cardiovascular system and the risks associated with aggressive CPP augmentation. 3) Cerebrovascular pressure reactivity deteriorates following decompressive craniectomy in most patients. The relationship between this impairment and neurological outcome needs further evaluation. 4) The impact of improved ICP control after decompressive craniectomy and its effect on neurological outcome after TBI has not yet been established and warrants prospective studies, 25 which are under way.
